During the past decade, X-Medica, s.r.o. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "X-Medica, s.r.o." are "Arthritis, Psoriatic" (1 trials), "Arthritis, Rheumatoid" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "X-Medica, s.r.o." in a lesser frequency.

Most popular intervention types in "X-Medica, s.r.o." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "CP-690,550" (1 trials), "Methotrexate" (1 trials), "PF-06410293" (1 trials), "Placebo Methotrexate" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "X-Medica, s.r.o." are 3 trials for "All" genders.

Currently, there are NaN active trials in "X-Medica, s.r.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in X-Medica, s.r.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in X-Medica, s.r.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".